The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).
Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!
Resource Search
Search Results
Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries
Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries View Report December, 2021 In this Report: Topic(s): Multipurpose Prevention Technology Pipeline Landscape
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review July, 2021 click to view Report In this Report: Topic(s): Compounds with Multiple Potential Activities
Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS)
Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS) November 2018 click to view Guidance Document In this Technical Brief: Topic(s): Regulatory Assessment Levonorgestrel Intrauterine System LEAP LNG-IUS Region(s): United States
2017 IMPT Annual Report
2017 IMPT Annual Report March 2018 click to view Report In this Report: Topic(s): Advocacy Collective Impact MPTs
2016 IMPT Annual Report
2016 IMPT Annual Report April 2017 The IMPT’s second Annual Report highlights another year of the Initiative’s accomplishments. This includes an overview of the year’s technical convenings, task force work in Kenya, the IMPT’s role in numerous conferences, as well as work toward market access coordination, and other points of potential interest. Building from 2015, […]
Hormonal contraceptive eligibility for women at high risk of HIV. Guidance Statement
Hormonal contraceptive eligibility for women at high risk of HIV. Guidance Statement 01 March 2017 click to view Report In this Report: Health Risk(s): Unintended Pregnancy Product Type(s): Hormonal Contraceptives Topic(s): Reproductive Health
Family Planning. Evidence Brief. Expanding contraceptive choice
Family Planning. Evidence Brief. Expanding contraceptive choice 31 January 2017 click to view Report In this Report: Health Risk(s): Unintended Pregnancy Topic(s): Reproductive Health
The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa
The importance of sexual and reproductive health and rights to prevent HIV in adolescent girls and young women in eastern and southern Africa 01 January 2017 click to view Report In this Report: Health Risk(s): HIV Topic(s): Advocacy Reproductive Health Social/Behavioral Context SRH Linkages
Technical Meeting on Hormonal Contraception (HC) in MPTs
Technical Meeting on Hormonal Contraception (HC) in MPTs 12 September 2016 Washington, DC, USA click to view Report In this Report: Product Type(s): ARVs Contraceptives MPTs Topic(s): Product Development Product Trials
2015 IPM Annual Report: New Hope for Women’s HIV Prevention
2015 IPM Annual Report: New Hope for Women’s HIV Prevention September 2016 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs
Contraception for HIV-infected Adolescents
Contraception for HIV-infected Adolescents August 2016 click to view Report In this Report: Health Risk(s): Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Reproductive Health
2016 Pipeline Report. HIV and TB. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development
2016 Pipeline Report. HIV and TB. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development 15 July 2016 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Vaccines Topic(s): Advocacy Education
AVAC Report 2016 – Big Data Real People
AVAC Report 2016 – Big Data Real People July 2016 click to view Report In this Report: Topic(s): Advocacy
Sixty-Ninth World Health Assembly. Draft global health sector strategies – Sexually transmitted infections, 2016-2021
Sixty-Ninth World Health Assembly. Draft global health sector strategies – Sexually transmitted infections, 2016-2021 16 May 2016 click to view Report In this Report: Health Risk(s): STI / STD
2015 IMPT Annual Report
2015 IMPT Annual Report April 2016 The IMPT’s inaugural Annual Report highlights the Initiative’s accomplishments in 2015 and our recent progress toward making MPTs a reality. It also gives an overview of the current MPT product pipeline and reports on global MPT investments. As you read through the Annual Report, we hope you will consider […]
Understanding the Potential for Multipurpose Prevention fo Pregnancy and HIV: Results from surveys assessing four hypothetical concept profiles of Multipurpose Prevention Technologies (MPTs) in Uganda, Nigeria, and South Africa
Understanding the Potential for Multipurpose Prevention fo Pregnancy and HIV: Results from surveys assessing four hypothetical concept profiles of Multipurpose Prevention Technologies (MPTs) in Uganda, Nigeria, and South Africa 2016 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives MPTs Topic(s): MPTs Reproductive Health SRH Linkages
What’s next for the Woman’s Condom? Celebrating a successful conclusion to the POW PDP
What’s next for the Woman’s Condom? Celebrating a successful conclusion to the POW PDP January 2016 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Contraceptives Topic(s): MPTs Product Development Reproductive Health
Developing sustainable markets for the Woman’s Condom – Global Report
Developing sustainable markets for the Woman’s Condom – Global Report December 2015 click to view Report In this Report: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms
National HIV/AIDS Strategy for the United States: Updated to 2020
National HIV/AIDS Strategy for the United States: Updated to 2020 01 December 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Other or N/A Topic(s): Education Reproductive Health
Fast-Tracking combination prevention
Fast-Tracking combination prevention 19 October 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Other or N/A Topic(s): Advocacy
On the Fast-Track to end AIDS. UNAIDS 2016-2021 Strategy
On the Fast-Track to end AIDS. UNAIDS 2016-2021 Strategy 19 October 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Other or N/A Topic(s): Advocacy
Research and Development of New Biomedical HIV Prevention Tools for Women and Girls: Combating the Global AIDS Epidemic Through a More Empowered Response in Sub-Saharan Africa
Research and Development of New Biomedical HIV Prevention Tools for Women and Girls: Combating the Global AIDS Epidemic Through a More Empowered Response in Sub-Saharan Africa September 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Vaccines Topic(s): Product Development
HIV, HCV, TB: 2015 Pipeline Report
HIV, HCV, TB: 2015 Pipeline Report 17 July 2016 click to view Report In this Report: Health Risk(s): Hepatitis HIV Product Type(s): Vaccines Topic(s): Product Development
HIV Prevention Research & Development Funding Trends, 2000-2014: Investing in innovation in an evolving global health and development landscape
HIV Prevention Research & Development Funding Trends, 2000-2014: Investing in innovation in an evolving global health and development landscape July 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): HIV Treatment Microbicides MPTs Vaccines Topic(s): Funding MPTs Product Development
How AIDS changed everything — MDG6: 15 years, 15 lessons of hope from the AIDS response: Fact Sheet
How AIDS changed everything — MDG6: 15 years, 15 lessons of hope from the AIDS response: Fact Sheet July 2015 click to view Report In this Report: Health Risk(s): HIV Product Type(s): Other or N/A Topic(s): Education Reproductive Health
2015 IMPT Joint Steering Committee & SACC Meeting
2015 IMPT Joint Steering Committee & SACC Meeting June 2015 click to view Report In this Report: Topic(s): Collective Impact Funding MPTs Product Development Product Introduction / Uptake Region(s): Global Working Group(s): (SACC) Supporting Agency Collaboration Committee
CCTN and MPT Stakeholder Round Table on Hormonal Contraceptives (HC) in MPTs Report
CCTN and MPT Stakeholder Round Table on Hormonal Contraceptives (HC) in MPTs Report 20 May 2015 click to view Report In this Report: Product Type(s): Hormonal Contraceptives Topic(s): Product Development Reproductive Health
Round Table on Commercialization and Social-Behavioral Issues for MPTs
Round Table on Commercialization and Social-Behavioral Issues for MPTs 17 March 2015 Bethesda, MD, USA Held at the Annual MTN Meeting, this round table session examined the complex commercialization and social-behavioral (CSB) issues related to successful MPT development and guide the prioritization of CSB activities. The convening focused particularly on end-user perspectives, service delivery, and […]
G-Finder 2014 – Reproductive Health: R&D for the Developing World
G-Finder 2014 – Reproductive Health: R&D for the Developing World February 2015 click to view Report In this Report: Health Risk(s): General SRH HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives MPTs Topic(s): Product Development Region(s): Global
Annual Report to Congress on the President’s Emergency Plan for AIDS Relief
Annual Report to Congress on the President’s Emergency Plan for AIDS Relief 2015 click to view Report In this Report: Health Risk(s): Other Product Type(s): Other or N/A
Biomedical AIDS research: recent and upcoming advance
Biomedical AIDS research: recent and upcoming advance 2015 click to view Report In this Report: Health Risk(s): HIV STI / STD Product Type(s): Microbicides Vaccines Other or N/A Topic(s): Epidemiology
WHO Statement on Public Disclosure of Clinical Trial Results
WHO Statement on Public Disclosure of Clinical Trial Results 2015 click to view Report In this Report: Health Risk(s): Other Product Type(s): Other or N/A Topic(s): Policy Product Trials
2014 IPM Annual Report: The Promise of Prevention for Women
2014 IPM Annual Report: The Promise of Prevention for Women 2015 click to view Report In this Report: Health Risk(s): Other Product Type(s): Other or N/A Topic(s): Reproductive Health